Skip navigation
Universidade de Brasília
Use este identificador para citar ou linkar para este item: http://repositorio.unb.br/handle/10482/48547
Arquivos associados a este item:
Arquivo Descrição TamanhoFormato 
ARTIGO_PersistentNewOnset.pdf1,02 MBAdobe PDFVisualizar/Abrir
Registro completo de metadados
Campo DCValorIdioma
dc.contributor.authorAlmeida, Ricardo Titze de-
dc.contributor.authorCunha, Thaylise Ramalho da-
dc.contributor.authorSilva, Letícia Dias dos Santos-
dc.contributor.authorFerreira, Clarisse Santos-
dc.contributor.authorSilva, Caroline Pena-
dc.contributor.authorRibeiro, Adriana Pinheiro-
dc.contributor.authorSantos Júnior, Agenor de Castro Moreira-
dc.contributor.authorBrandão, Pedro Renato de Paula-
dc.contributor.authorSilva, Andrezza Paula Brito-
dc.contributor.authorRocha, Márcia Cristina Oliveira da-
dc.contributor.authorXavier, Mary‑Ann Elvina-
dc.contributor.authorAlmeida, Simoneide Souza Titze de-
dc.contributor.authorShimizu, Helena Eri-
dc.contributor.authorRodrigues, Raimundo Nonato Delgado-
dc.date.accessioned2024-07-04T18:42:16Z-
dc.date.available2024-07-04T18:42:16Z-
dc.date.issued2022-02-08-
dc.identifier.citationALMEIDA, Ricardo Titze de et al. Persistent, new‑onset symptoms and mental health complaints in Long COVID in a Brazilian cohort of non‑hospitalized patients. BMC Infectious Diseases, [S. l.], v. 22, 133, 2022. DOI: https://doi.org/10.1186/s12879-022-07065-3. Disponível em: https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-022-07065-3. Acesso em: 03 jul. 2024.pt_BR
dc.identifier.urihttp://repositorio2.unb.br/jspui/handle/10482/48547-
dc.language.isoengpt_BR
dc.publisherBMCpt_BR
dc.rightsAcesso Abertopt_BR
dc.titlePersistent, new‑onset symptoms and mental health complaints in Long COVID in a Brazilian cohort of non‑hospitalized patientspt_BR
dc.typeArtigopt_BR
dc.subject.keywordMemória - aspectos fisiológicospt_BR
dc.subject.keywordDepressão mentalpt_BR
dc.subject.keywordSono - qualidadept_BR
dc.subject.keywordSaúde mentalpt_BR
dc.subject.keywordCovid-19pt_BR
dc.rights.license© The Author(s) 2022. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativeco mmons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.pt_BR
dc.identifier.doihttps://doi.org/10.1186/s12879-022-07065-3pt_BR
dc.description.abstract1Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections lead to acute- and chronic Long COVID (LC) symptoms. However, few studies have addressed LC sequelae on brain functions. This study was aimed to examine if acute symptoms of coronavirus disease 2019 (COVID-19) would persist during LC, and if memory problems would be correlated with sleep, depressive mood, or anxious complaints. Methods: Our work followed a cohort of 236 patients from two public hospitals of the Federal District in mid-west‑ern Brazil. Patients’ interviews checked for clinical symptoms during acute and LC (5–8 months after real-time reverse transcription polymerase chain reaction, RT-qPCR). Results: Most cases were non-hospitalized individuals (86.3%) with a median age of 41.2 years. While myalgia (50%), hyposmia (48.3%), and dysgeusia (45.8%) were prevalent symptoms in acute phase, fatigue (21.6%) followed by headache (19.1%) and myalgia (16.1%) commonly occurred during LC. In LC, 39.8% of individuals reported memory complaints, 36.9% felt anxious, 44.9% felt depressed, and 45.8% had sleep problems. Furthermore, memory complaints were associated with sleep problems (adjusted OR 3.206; 95% CI 1.723–6.030) and depressive feelings (adjusted OR 3.981; 95% CI 2.068–7.815). Conclusions: The SARS-CoV-2 infection leads to persistent symptoms during LC, in which memory problems may be associated with sleep and depressive complaints.pt_BR
dc.identifier.orcidhttps://orcid.org/0000-0002-5019-4742pt_BR
dc.contributor.affiliationUniversity of Brasília, Central Institute of Sciences, Research Center for Major Themespt_BR
dc.contributor.affiliationUniversity of Brasília, Central Institute of Sciences, Research Center for Major Themespt_BR
dc.contributor.affiliationUniversity of Brasília, Central Institute of Sciences, Research Center for Major Themespt_BR
dc.contributor.affiliationUniversity of Brasília, Central Institute of Sciences, Research Center for Major Themespt_BR
dc.contributor.affiliationUniversity of Brasília, Central Institute of Sciences, Research Center for Major Themespt_BR
dc.contributor.affiliationArmed Forces Hospital, Learning and Research Technical Board,pt_BR
dc.contributor.affiliationCentral Laboratory of Public Health of the Federal District, Brasília, Brazilpt_BR
dc.contributor.affiliationUniversity of Brasília, Central Institute of Sciences, Research Center for Major Themespt_BR
dc.contributor.affiliationUniversity of Brasília, Central Institute of Sciences, Research Center for Major Themespt_BR
dc.contributor.affiliationFederal District Strategic Health Management Institute, Brasília, Brazilpt_BR
dc.contributor.affiliationUniversity of Brasília, Central Institute of Sciences, Research Center for Major Themespt_BR
dc.contributor.affiliationCentral Institute of Sciences, Technology for Gene Therapy Laboratory-FAV, University of Brasíliapt_BR
dc.contributor.affiliationUniversity of Brasília, Central Institute of Sciences, Research Center for Major Themespt_BR
dc.contributor.affiliationCentral Institute of Sciences, Technology for Gene Therapy Laboratory-FAV, University of Brasíliapt_BR
dc.contributor.affiliationDepartment of Collective Health, Research Center for Major Themes, University of Brasíliapt_BR
dc.contributor.affiliationUniversity of Brasília, Central Institute of Sciences, Research Center for Major Themespt_BR
dc.description.unidadeFaculdade de Agronomia e Medicina Veterinária (FAV)pt_BR
dc.description.unidadeFaculdade de Ciências da Saúde (FS)pt_BR
dc.description.unidadeDepartamento de Saúde Coletiva (FS DSC)pt_BR
dc.description.unidadeInstituto de Ciências Biológicas (IB)pt_BR
dc.description.unidadeFaculdade de Medicina (FM)pt_BR
dc.description.ppgPrograma de Pós-Graduação em Ciências da Saúdept_BR
dc.description.ppgPrograma de Pós-Graduação em Nanociência e Nanobiotecnologiapt_BR
Aparece nas coleções:Artigos publicados em periódicos e afins
UnB - Covid-19

Mostrar registro simples do item Visualizar estatísticas



Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.